Fuad El-Hibri
Fuad El-Hibri (born March 2 1958) is an American businessman, and CEO of Emergent BioSolutions
Contents
Biography
Early Life
Fuad El-Hibri (born March 2 1958) in Hildesheim, Germany[1] spent his childhood equally in Europe and the Middle East before coming to the USA to get an economics degree from Stanford and an MBA from Yale[1]
Education
Mr.El-Hibri earned a Masters Degree in Public and Private Management from Yale University and a Bachelors Degree with Honors in Economics from Stanford University.
Early Career
Fuad El-Hibri served as president of Digicel from August 2000 to February 2005. Mr. El-Hibri served as the president of East West Resources Corporation from September 1990 to January 2004.
Mr. El-Hibri was a member of the senior management team of Speywood, LTD., in the United Kingdom. and organized and directed the management buyout of Porton Products Ltd. El-Hibri reorganized Porton, and was advisor to the senior management team involved in the oversight of operations and served as a senior associate and resident project manager at Booz Allen Hamilton and as a manager of Citicorp in New York (Mergers and Acquisitions), and in Jeddah, Saudi Arabia (Operations and Credit).
Mr. El-Hibri has been chairman of East West Resources Corporation, a venture capital and financial consulting firm, since June 1990. He served as the chairman of Digicel Holdings from August 2000 to October 2006. He serves as director of Emergent BioDefense Operations Lansing Inc.
Current Career
El-Hibri has been Director and CEO of Emergent BioSolutions since 2004 and He serves as Chairman and Treasurer of El-Hibri Charitable Foundation. Mr.El-Hibri serves as a member of the board of trustees of American University. He is a member of the board of directors of the International Biomedical Research Alliance (an academic joint venture among the National Institutes of Health, Oxford University and Cambridge University). Mr El-Hibri is also a member of the board of trustees of the National Health Museum.
1999 Testimony
In his June 30, 1999, testimony before "The Subcommittee on National Security, Veterans Affairs, and International Relations of the House Committee on Government Reform," El-Hibri stated that:[1]
- "Three companies currently hold voting equity in BioPort: Intervac LLC and Intervac Management LLC, which are both Maryland limited liability companies, and ichigan Biologic Products, Inc., a Michigan corporation. Intervac LLC is the controlling shareholder. Intervac LLC is owned by Admiral William J. Crowe, Jr., my wife Nancy and me, and I and F Holdings N.V., a Netherlands Antilles investment company owned by my father Ibrahim El-Hibri. As mentioned earlier, I and F Holdings is an investment company in biotech operations, which previously had invested in the management buy-out of Porton Products Ltd. Admiral Crowe and I are the controlling members of Intervac LLC."
Suber says that, "While Fuad El-Hibri was [sic] needed no financing to take over the State of Michigan biologic lab, he did need a front man to reassure the military with respect to their Anthrax contract. He already had the perfect front man in former chairman of the Joint Chiefs of Staff, Adm. William J. Crowe Jr. Adm. Crowe had a long history of involvement with the El-Hibri family. Crowe owns 22.5 percent of Intervac shares, although he hasn’t invested a penny in the venture." [2]
- Trustee, American University
External links
- Tom Suber, "3500 Martin Luther King Jr. Blvd", Pipeline.com, February 2003.
- Fuad El-Hibri Blog
Resources and articles
Related Sourcewatch articles
References
- ↑ 1.0 1.1 Muslim CEOs of U.S. firms fight terrorism stop evil. USA Today.
Cite error: Invalid
<ref>tag; name "usatoday" defined multiple times with different content
